Capital Flow Monitor · Sponsors · CIK 1710088

Aeovian Pharmaceuticals, Inc.

2930 Domingo Ave., Suite 145, Berkeley, CA, 94705 · 510-961-1148

Pharmaceuticals · Corporation· inc. DELAWARE true

Fit score

—

Offering

$55.0M

Sold

$55.0M

% sold

100.0%

Investors

13

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2025-12-22 D ·current 506(b) $55.0M $55.0M 100.0% 13 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

  • Allison J. Hulme — Executive Officer / Director, Berkeley, CA
  • Micah Zajic — Executive Officer, Berkeley, CA
  • William Greene — Director, Berkeley, CA
  • Justin Gover — Director, Berkeley, CA
  • Richard Gaster — Director, Berkeley, CA
    1 other raise
  • Lars Ekman — Director, Berkeley, CA
  • Nils Regge — Director, Berkeley, CA
    1 other raise
  • Themasap Khan — Director, Berkeley, CA
    2 other raises
  • Youssef Bennani — Director, Berkeley, CA
  • John Kincaid — Executive Officer, Berkeley, CA
  • Davis Ryman — Executive Officer, Berkeley, CA

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.